Bank of Montreal
AGRX

Bank of Montreal’s Agile Therapeutics AGRX Stock Holding History

Bank of Montreal’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed -$6K – 5271
2021
Q1 		$6K Sell
2
-4
-67% -$21.6K ﹤0.01% 4606
2020
Q4 		$34K Buy
6
+4
+200% +$23.5K ﹤0.01% 4152
2020
Q3 		$13K Sell
2
-1
-33% -$5.73K ﹤0.01% 4045
2020
Q2 		$17K Buy
3
+2
+200% +$10.4K ﹤0.01% 3934
2020
Q1 		$2K Hold
1
– – ﹤0.01% 3910
2019
Q4 		$3K Hold
1
– – ﹤0.01% 4760
2019
Q3 		$1K Hold
1
– – ﹤0.01% 4692
2019
Q2 		$2K Hold
1
– – ﹤0.01% 4776
2019
Q1 		$2K Hold
1
– – ﹤0.01% 4175
2018
Q4 		$1K Hold
1
– – ﹤0.01% 4588
2018
Q3 		$0 Hold
1
– – ﹤0.01% 4951
2018
Q2 		$1K Hold
1
– – ﹤0.01% 4626
2018
Q1 		$3K Hold
1
– – ﹤0.01% 4011
2017
Q4 		$4K Buy
+1
New +$9.31K ﹤0.01% 3976

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's AGRX Position: Q2 2021 in Review

Bank of Montreal sold out of Agile Therapeutics (AGRX) in Q2 2021, closing a stake of 2 shares — an estimated $6K sold.

Bank of Montreal first reported a position in AGRX in Q4 2017 and held it in 14 quarters. The position peaked at $34K in Q4 2020. 64 funds tracked by Wall St. Rank hold AGRX as of Q2 2021.

  • Bank of Montreal reported no remaining Agile Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2 Agile Therapeutics shares in Q2 2021, an estimated $6K.
  • Bank of Montreal first reported a position in Agile Therapeutics in Q4 2017 and held it in 14 quarters.
  • Bank of Montreal's Agile Therapeutics position peaked at $34K in Q4 2020.
  • 64 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.